0.5235
Senseonics Holdings Inc stock is traded at $0.5235, with a volume of 4.03M.
It is down -1.95% in the last 24 hours and down -30.16% over the past month.
Senseonics Holdings, Inc., a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days. The company has a research and development license agreement with TypeZero Technologies, Inc. and Roche Diabetes Care, Inc. to develop a closed loop diabetes management system that allow users to automatically maintain tight glucose control while avoiding hypoglycemia. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
See More
Previous Close:
$0.5339
Open:
$0.5347
24h Volume:
4.03M
Relative Volume:
0.74
Market Cap:
$394.87M
Revenue:
$22.39M
Net Income/Loss:
$-60.39M
P/E Ratio:
-4.6825
EPS:
-0.1118
Net Cash Flow:
$-70.51M
1W Performance:
+3.72%
1M Performance:
-30.16%
6M Performance:
+68.11%
1Y Performance:
+21.15%
Senseonics Holdings Inc Stock (SENS) Company Profile
Name
Senseonics Holdings Inc
Sector
Industry
Phone
301-515-7260
Address
20451 Seneca Meadows Parkway, Germantown, MD
Compare SENS with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
SENS
Senseonics Holdings Inc
|
0.5235 | 380.69M | 22.39M | -60.39M | -70.51M | -0.1118 |
![]()
ABT
Abbott Laboratories
|
133.58 | 228.44B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
105.26 | 154.60B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
382.64 | 143.93B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
82.98 | 103.43B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
78.22 | 43.99B | 5.54B | 4.18B | 623.10M | 7.00 |
Senseonics Holdings Inc Stock (SENS) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Apr-10-25 | Initiated | Mizuho | Outperform |
Jul-19-23 | Initiated | Jefferies | Underperform |
Aug-19-21 | Initiated | H.C. Wainwright | Buy |
Apr-01-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
Mar-05-21 | Downgrade | Raymond James | Mkt Perform → Underperform |
Jan-21-21 | Downgrade | BTIG Research | Buy → Neutral |
Jan-20-21 | Downgrade | Craig Hallum | Hold → Sell |
Aug-11-20 | Upgrade | BTIG Research | Neutral → Buy |
Aug-11-20 | Upgrade | Craig Hallum | Sell → Hold |
Mar-13-20 | Downgrade | BTIG Research | Buy → Neutral |
Mar-13-20 | Downgrade | Guggenheim | Buy → Neutral |
Nov-13-19 | Downgrade | Canaccord Genuity | Buy → Hold |
Nov-13-19 | Downgrade | Craig Hallum | Buy → Hold |
Oct-23-19 | Initiated | Stifel | Buy |
Jul-05-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
Jan-29-19 | Initiated | Piper Jaffray | Neutral |
Aug-24-18 | Initiated | Dougherty & Company | Buy |
View All
Senseonics Holdings Inc Stock (SENS) Latest News
Continuous Glucose Monitoring Devices Market Forecast: Growth - openPR.com
Chief Medical Officer Kaufman Francine was granted 455,716 shares, increasing direct ownership by 21% to 2,599,910 units (SEC Form 4) - Quantisnow
Blood Glucose Monitoring Market Surges with Wearable Tech - openPR.com
Senseonics Raises $77.8 Million from Public Offering, Placement - marketscreener.com
Senseonics Holdings, Inc. Announces Closing of Public Offering, - GuruFocus
Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters' Option to Purchase Additional Shares, and Closing of Private Placement - The Manila Times
Senseonics Holdings, Inc. Secures $57.5 Million in Public Offering and $20.3 Million from Private Placement with Abbott Laboratories - Nasdaq
Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters’ Option to Purchase Additional Shares, and Closing of Private Placement - GlobeNewswire
Senseonics Secures Massive $77.8M Funding Boost as Abbott Backs Next-Gen Diabetes Monitor Launch - Stock Titan
Senseonics Holdings announces underwritten public offering - MSN
Diabetic Care Device Market Set for Significant Growth with 10.1% CAGR - GlobeNewswire Inc.
Senseonics Holdings, Inc. to Host Earnings Call - ACCESS Newswire
Revisiting Senseonics After 4 Years: Still A Big Investment Opportunity (NYSE:SENS) - Seeking Alpha
Senseonics announces pricing of $50 million public offering - MSN
Senseonics Holdings Announces Major Stock Offering Agreement - TipRanks
Constellation Brands, Senseonics, Estee Lauder - TradingView
Senseonics announces pricing of public offering of common stock - Medical Buyer
SENS: Key Developments and Market Insights | SENS Stock News - GuruFocus
Senseonics Prices $50 Million Public Offering - marketscreener.com
Senseonics Announces Pricing of $50 Million Public Offering of C - GuruFocus
Senseonics (SENS) Launches $50 Million Stock Offering - GuruFocus
Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement - citybiz
Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement | SENS Stock News - GuruFocus
Senseonics Secures $50M Funding Boost: Abbott Takes Strategic Stake in Diabetes CGM Innovation - Stock Titan
Senseonics Announces Pricing Of $50 Million Public Offering At $0.50 Per Share - marketscreener.com
Senseonics Kicks Off $50 Million Stock Offering; Discloses Private Placement of Up to $25 Million With Abbott Laboratories - marketscreener.com
Senseonics (SENS) Launches Public Offering of Common Stock | SENS Stock News - GuruFocus
Senseonics launches public stock offering and private placement - Investing.com
Senseonics launches public stock offering and private placement By Investing.com - Investing.com Nigeria
Senseonics Holdings Inc Enters Securities Purchase Agreement With Abbott - marketscreener.com
Senseonics announces common stock offering, no amount given - TipRanks
Senseonics ticks down after announcing stock sale, private placement with Abbott - TradingView
Senseonics Holdings Enters Agreement with Abbott Laboratories - TipRanks
Senseonics Announces Commencement of $50 Million Public Offering - GuruFocus
Senseonics Announces Commencement of $50 Million Public Offering of Common Stock and Concurrent Private Placement | SENS Stock News - GuruFocus
Senseonics Holdings, Inc. Announces Public Offering of Common Stock to Support Eversense 365 Launch and Development Efforts - Nasdaq
Senseonics Announces Commencement of $50 Million Public Offering of Common Stock and Concurrent Private Placement - The Manila Times
Senseonics Announces Commencement of $50 Million Public - GlobeNewswire
Raymond James Financial Inc. Buys New Stake in Senseonics Holdings, Inc. (NYSE:SENS) - Defense World
Senseonics Holdings Inc earnings beat, revenue fell short of estimates By Investing.com - Investing.com Nigeria
Senseonics Holdings Q1 revenue jumps 24% to USD 6.3 million - Medical Buyer
Senseonics targets $34M-$38M revenue in 2025 with Eversense 365 expansion - MSN
Senseonics Holdings (SENS) Reports Q1 Loss, Tops Revenue Estimates - MSN
Senseonics Earnings Call: Growth and Strategic Moves - TipRanks
Senseonics Holdings, Inc. (AMEX:SENS) Q1 2025 Earnings Call Transcript - Insider Monkey
Senseonics Holdings Inc (SENS) Q1 2025 Earnings Call Highlights: - GuruFocus
Earnings call transcript: Senseonics Q1 2025 reports mixed results, stock reacts negatively - Investing.com Canada
Senseonics: Q1 Earnings Snapshot - San Francisco Chronicle
Senseonics Holdings Inc (SENS) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ... By GuruFocus - Investing.com Canada
Senseonics Holdings Inc (SENS) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ... - Yahoo Finance
Senseonics Holdings, Inc. Reports First Quarter Financial Results - The Manila Times
Senseonics Holdings Inc Stock (SENS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):